Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...

Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease ...

9 in Pediatric Blood & Cancer. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR ...

A family from South London are making a desperate appeal on behalf of their 19-year-old daughter. Natassa urgently needs to ...

HealthDay News — For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T ...

Acute lymphocytic leukaemia (ALL) is a cancer of the blood and bone marrow, specifically affecting lymphocytes. The disease progresses rapidly and creates immature blood cells, rather than mature ...

Chronic lymphocytic leukemia (CLL ... Bone marrow is a soft, spongy substance within bones that produces blood cells. CLL is the result of various genetic mutations in the DNA of cells that ...

B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among ...

Chronic lymphocytic leukemia (CLL) is a type of cancer affecting the bone marrow lymphocytes. It can affect B or T cells and may be slow- or fast-growing. CLL is a common type of leukemia ...

They can also review the size and shape of different blood cells using this test. In CLL, lymphocytic cells begin to grow and divide uncontrollably. This leads to high levels of lymphocytes in the ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...